Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Interleukin-1 (IL-1) family is a group of cytokines that play a central role in the regulation of immune and inflammatory responses. IL-1 is a key mediator of innate immunity and inflammation, with its family members involved in both proinflammatory and anti-inflammatory processes. Dysregulation contributes to autoinflammatory diseases. The family consists of 11 cytokines including agonists (IL-1α, IL-1β, IL-18, IL-33, IL-36α, IL-36β, and IL-36γ), receptor antagonists (IL-1Ra, IL-36Ra, and IL-38), and an anti-inflammatory cytokine (IL-37).
Block IL-1 receptor signaling, neutralize IL-1 ligands
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 1 Family Member (IL-1).